About All of Us

Its About All of Us

Champions of Hope-

Champions of Hope-
Patients/Caregivers

 

img_1595

 

charlie-t-jim-smog-12-2014

 

img_0263

 

tphoto

 

mao-w

 

praisegate_444
 
 
 
00f3def6-edd8-4e6e-9e0d-ca5fe00e1481-1
 
 
 

gracynpickle1stbday_43-1

 

heidi-coral-scarf-1st-crop-web

 

unnamed-1
 
 
unnamed-2
 
 
img_1609
 
 
img_1597
 
 
dana-parker-and-rob-brennan
 
 
dana-parker
 
 
joanne-annie-and-mary-anne-df-symposium-2016-3
 
 
joanne-annie-and-mary-anne-df-symposium-20163
 
 
tci-headshot-hr-1
 
 
img_6206
 
 
unnamed-1
 
 
sisters
 
 
 
 

'Sunflower Brigade" - Boston

 

About Us- Its about all of us

 

 

Dr. Mitchell D. Achee
NLMSF Medical Advisory Committee Chair
LMS Survivor
Diagnostic Radiology - Kaiser Permanente, Denver, CO
 

The National Leiomyosarcoma Foundation (NLMSF) was founded on July 14, 2001 and exists today as a 501(c)(3) charitable non-profit organization and a member of the GuideStar Exchange (Silver Participant). The Foundation continues to be dedicated to general sarcoma and specific LMS research projects that hold promise for advancing LMS treatment breakthroughs.

We honor our patients/ families/caregivers for supporting and believing in the mission of the foundation.

We honor our sarcoma/LMS researchers for their collaborative partnership with the foundation for patient education /advocacy.

The foundation and its followers stand behind the researchers in funding support of their sarcoma/LMS research efforts. They are our lifeline for survivorship.

Our Mission Matters: 

  • Patient/family/ caregiver education and support
  • LMS research funding
  • Patient advocacy
  • Resource collaboration with other organizations 
 
unnamed-5
 
Dr. Raphael Pollock
 
Prof. and Director, Division of Surgical Oncology Vice Chairman, Clinical Affairs, Dept. of Surgery Surgeon in Chief, James Comprehensive Cancer Center/Ohio State University Health System
 
The National Leiomyosarcoma Foundation is a premier patient advocacy organization devoted to this rare form of cancer, provides the basis outstanding service in so many different ways: as a source of authoritative information for leiomyosarcoma patients via numerous annual patient education conferences held throughout the United States annually, by connecting patients to physician experts in this disease for their treatment, and by fundraising to support the cutting edge research needed if we are to successfully develop new therapies for leiomyosarcoma. Unique in these functions, the National Leiomyosarcoma Foundation, under the leadership of Mitch and Annie Achee, is a beacon of hope for patients, caregivers, and researchers alike!

 

Staff portrait George Demetri, M.D.

Dr. George Demetri

Director, Center for Sarcoma and Bone Oncology
 
 

jonathan_fletcher-photo

Dr. Jonathan Fletcher
 
Assoc. Professor of Pathology
Harvard Medical Pathology - Dana FarberBrighan & Women's Cancer Center
 
"Crucial research support from NLMSF brings together leiomyosarcoma research programs from several countries. This support is enabling a “divide and conquer” approach so that coordinated studies from different leiomyosarcoma research teams can move more quickly towards new leiomyosarcoma therapies."-Dr. Fletcher
 

matt-van-de-rijn

Dr. Matt Van de Rijn 

Surgical Pathologist and Molecular Pathologist, 

Stanford University Medical Center

"For more than a decade, the National Leiomyosarcoma Foundation has supported the research on novel prognostic markers and potential therapeutic targets for LMS in our laboratory at Stanford University.  This support has allowed us to pursue many projects and we hope to continue this collaboration in the future."-Dr. Matt Van de Rijn

  
download-11

Dr. Kurt Weiss, M.D.  

Orthopedic Surgical Oncologist Ass't Prof. Orthopedic Surgery Director - Bone /STS lab UPMC Cancer Center - Pittsburgh

The National Leiomyosarcoma Foundation (NLMSF) is truly committed to research, education, and support. They have been a major force in building successful collaborations between researchers so that we can better serve our heroic patients. As a sarcoma surgeon and scientist, I am grateful for the NLMSF's continued support and unwavering commitment to find better treatments for leiomyosarcoma.

 
drravi1

Dr. Vinod Ravi

Assistant Professor, Department of Sarcoma Medical Oncology, Division of Cancer Medicine, the University of Texas M.D. Anderson Cancer Center, Houston, Texas

Adjunct Faculty, Translational Genomics Research Institute, Phoenix, Arizona

"The NLMSF is providing valuable support to the leiomyosarcoma patient community with its collaborative patient education symposia across the USA, in the UK, and Canada. The LMS Research Work Group at MD Anderson appreciated the patient program opportunity with the NLMSF, and future LMS research support will be important."-Dr. Ravi

 

 
 

 

 
 

Everyday Heroes Among Us

Everyday Heroes Among Us ---         Our Researchers

Below are our researchers introduced in alphabetical order:

asvat_yasmin

Yasmin Asvat, Ph.D. Clinical Psychologist Siteman Cancer Center Barnes-Jewish Hospital
url

Edwin Choy, M.D. / Ph.D. (Medical Oncologist) Assistant Professor of Medicine Harvard Medical School Dana Farber/Harvard Cancer Center Massachusetts General Hospital Director of Sarcoma Clinical Research Clinical Director of Sarcoma Oncology
url2

Dr. Rashmi Chugh, M.D. Rashmi Chugh, M.D. (Medical Oncologist) Clinical Assistant Professor of Internal Medicine—Hematology/Oncology University of Michigan Health System Washington University School of Medicine in St. Louis
capture

Rebecca Gladdy, MD, PhD, FRCSC Division of General Surgery Mount Sinai Hospital 600 University Avenue Toronto, ON
jones_robin-1

Dr. Robin Jones, BSc, MB, MRCP, MD Head of Sarcoma Unit, Royal Marsden Hospital, London

Anusha Kalbasi, MD Health Sciences Clinical Instructor Jonsson Comprehensive Cancer Center – Ribas Lab Division of Molecular and Cellular Oncology UCLA Department of Radiation Oncology
unnamed

Dr. Khandan Keyomarsi, Ph.D. Professor, Department of Experimental Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
unnamed-4

Alexander Lazar, M.D., Ph.D. Associate Professor, Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX Director, Selective (Soft Tissue) Pathology Fellowship Training Program, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
fullsizerender-1

Dr. Gonzalo Lopez Research Scientist Biomedical Research Tower (BRT) Ohio state University

Dr. Robert Maki, MD Sarcoma Program Leader/Medical Director Center for Cancer Therapies Monter Cancer Center New Hyde Park, New York

Mohammed Milhem, MD University of Iowa Co-Leader, Melanoma Deputy Director, Clinical Cancer Service Research for Holden Comprehensive Cancer Center Clinical Professor, Melanoma and Sarcoma/Clinical Trials Program
unnamed-6

Dr. Sujana Movva   Menatology/Oncology specialist/researcher Fox Chase Cancer Center - Philadelphia

Dr. Scott H. Okuno, M.D. Professor, Oncology Mayo Clinic, Rochester, MN Medical Officer/Chair, Clinical Trials, SARC
unnamed12

Dr. Seth Pollack, MD Clinical Research Division, Program in Immunology Seattle Cancer Care Alliance
denise-reinke

Denise Reinke, MS, NP, MBA  President & CEO SARCDenise Reinke, MS, NP, MBA  President & CEO SARC
unnamed-8

Scott Michael Schuetze MD, PhD Professor, Medical Oncology University of Michigan Health System
unnamed-2

Dr. Arun Singh Medical oncologist, Santa Monica, California UCLA Medical Center and UCLA Medical Center Santa Monica.
195795_somiah_n

Neeta Somaiah, M.D. Assistant Professor, Department of Sarcoma Medical Oncology, MD Anderson Cancer Center
unnamed-4

Dr. Brian Van Tine Research Oncologist Washington University School of Medicine 
 
 
   

                    

 

 

Reaching For the Cure Together